• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ZLD 16.2% 79.0¢

ZELIRA THERAPEUTICS LIMITED - Corporate Spotlight

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

No Corporate Spotlight currently available.

(20min delay)
Last
79.0¢
Change
0.110(16.2%)
Mkt cap ! $8.964M
Open High Low Value Volume
70.0¢ 79.0¢ 70.0¢ $1.983K 2.605K

Buyers (Bids)

No. Vol. Price($)
1 3359 77.0¢
 

Sellers (Offers)

Price($) Vol. No.
79.0¢ 261 1
View Market Depth
Last trade - 15.06pm 23/08/2024 (20 minute delay) ?
Last
79.0¢
  Change
0.110 ( 0.00 %)
Open High Low Volume
79.0¢ 79.0¢ 79.0¢ 1266
Last updated 15.06pm 23/08/2024 ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.